High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review

Haemophilia. 2013 Jan;19(1):e50-3. doi: 10.1111/hae.12033. Epub 2012 Oct 11.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Aged
  • Cardiovascular Diseases*
  • Factor VIII / administration & dosage*
  • Hemophilia A / drug therapy*
  • Hemorrhage / prevention & control
  • Hemostatics / administration & dosage*
  • Humans
  • Male
  • Recombinant Proteins / administration & dosage
  • von Willebrand Factor / administration & dosage*

Substances

  • Hemostatics
  • Recombinant Proteins
  • von Willebrand Factor
  • Factor VIII